Recent Progress of Deep Learning in Drug Discovery

Area of Science:

• Artificial Intelligence
• Machine Learning
• Drug Discovery

Background:

• Deep learning, a subset of machine learning utilizing neural networks, is increasingly vital across scientific fields.
• Its application in drug discovery is rapidly expanding due to its pattern recognition capabilities.

Purpose of the Study:

• To review mainstream deep learning architectures relevant to drug discovery.
• To explore the applications of these architectures in key areas of pharmaceutical research.
• To discuss future trends and challenges in applying deep learning to drug discovery.

Main Methods:

• Review of prominent deep learning architectures: deep neural networks (DNNs), convolutional neural networks (CNNs), and recurrent neural networks (RNNs).
• Exploration of their use in molecular de novo design, property prediction, biomedical imaging analysis, and synthetic planning.

Main Results:

• DNNs, CNNs, and RNNs demonstrate significant utility in various drug discovery tasks.
• These models facilitate advancements in generating novel molecular structures and predicting compound properties.
• Applications extend to interpreting complex biomedical images and optimizing synthetic routes.

Conclusions:

• Deep learning architectures offer powerful tools for accelerating and enhancing drug discovery processes.
• Continued research and development are crucial to overcome existing challenges and unlock the full potential of AI in pharmaceuticals.
• Future directions include refining models and integrating them into broader drug development pipelines.